At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders
--
Minimum 15 minutes delayed. Source: LSEG
Upcoming Events
More events are coming soon.
Recent News
-
June 3, 2025
New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors
Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors MINNEAPOLIS , June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical
-
May 20, 2025
Tactile Medical to Present at Upcoming Investor Conferences in June
MINNEAPOLIS , May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be participating in two upcoming investor
-
May 5, 2025
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results
MINNEAPOLIS , May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025 .